Protective effect of EDTA preadministration on renal ischemia

BMC Nephrology

Volumn 7, Issue , 2006, Pages

  Foglieni, Chiara ^a   Fulgenzi, Alessandro ^b   Ticozzi, Paolo ^b   Pellegatta, Fabio ^b   Sciorati, Clara ^a   Belloni, Daniela ^b   Ferrero, Elisabetta ^a   Ferrero, Maria Elena ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CREATININE; EDETIC ACID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ACUTE KIDNEY FAILURE; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL PERMEABILITY; CELL ADHESION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; FUNCTIONAL ASSESSMENT; HEMODYNAMICS; HISTOPATHOLOGY; IN VIVO STUDY; KIDNEY FUNCTION TEST; KIDNEY INJURY; KIDNEY ISCHEMIA; MALE; NONHUMAN; POLYMORPHONUCLEAR CELL; POST HOC ANALYSIS; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; REPERFUSION; UREA NITROGEN BLOOD LEVEL;

ACUTE KIDNEY INJURY; ANIMALS; BLOOD UREA NITROGEN; CAPILLARY PERMEABILITY; CELL ADHESION; CHELATING AGENTS; CREATININE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EDETIC ACID; HEMODYNAMICS; ISCHEMIA; KIDNEY; MACROPHAGE-1 ANTIGEN; MALE; NEUTROPHILS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33746000756     PISSN: 14712369     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-7-5     Document Type: Article

References (38)

1. Sanchez-Fructuoso Al, Prats D, Barrientos A: Treatment of chronic lead intoxication. Ann Intern Med 1999, 131:716.
2. Lin JL, Ho HH, Yu CC: Chelation therapy for patients with elevated body lead burden and progressive renal insufficiency. A randomized; controlled trial. Ann Intern Med 1999, 130:7-13.
3. Lin JL, Lin-Tan DT, Hsu KH, Yu CC: Environmental lead exposure and progression of chronic renal diseases in patients without diabetes. N Engl J Med 2003, 348:277-286.
4. Cohen A, Bergamaschi E, Mutti A: Experimental model of lead nephropathy II. Effect of removal from lead exposure and chelation treatment with dimercaptosuccinic acid (DMSA). Environ Res 1992, 58:35-54.
5. Vaziri ND, Liang K, Ding Y: Increased nitric oxide inactivation by reactive oxygen species in lead-induced hypertension. Kidney Int 1999, 6:1492-1498.
6. Ding Y, Vaziri ND, Gonick HC: Lead-induced hypertension II Response to sequential infusions of L-arginine; superoxide dismutase; and nitroprusside. Environ Res 1998, 76:107-113.
7. Samuni AM, Afeworki M, Stein W, Yordanov AT, DeGraff W, Krishna MC, Mitchell JB, Brechbiel MW: Multifunctional antioxidant activity of HBED iron chelator. Free Radic Biol Med 2001, 30:170-177.
8. Bonventre JV: Mechanisms of ischemic acute renal failure. Kidney Int 1993, 43:1160-1178.
9. Thadhani R, Pascual M, Bonventre JV: Acute renal failure. N Engl J Med 1996, 334:448-1460.
10. Moncada S, Higgs A: The L-Arginine-nitric oxide pathway. New Eng J Med 1993, 329:2002-2011.
11. Freishlag JA, Hanna D: Neutrophil (PMN) phagocytosis and chemotaxis after reperfusion injury. J Surg Res 1992, 52:152-156.
12. Granger DN: Role of xanthine oxidase and granulocytes in ischemia- reperfusion injury. Am J Physiol 1988, 24:1269-H1275.
13. Baker JE: Erythropoietin mimics ischemic preconditioning. Vascul Pharmacol 2005, 42:233-241.
14. Weber NC, Schlack W: The concept of anaesthetic-induced cardioprotection. mechanism of action. Best Pract Res Clin Anaesthesiol 2005, 19:429-443.
15. Isobe H, Okajima K, Uchiba M, Harada N, Okabe H: Antithrombin prevents endotoxin-induced hypotension by inhibiting the induction of nitric oxide synthase in rats. Blood 2002, 99:1638-45.
16. Isobe H, Okajima K, Uchiba M, Mizutani A, Harada N, Nagasaki A, Okabe K: Activated protein C prevents endotoxin-induced hypotension in rats by inhibiting excessive production of nitric oxide. Circulation 2001, 104:1171-5.
17. Molina A, Ubeda M, Escribese MM, Garcia-Bermejo L, Sancho D, de Lema GP, Liano F, Cabanas C, Sanchez-Madrid F, Mampaso F: Renal ischemia/reperfusion injury, functional tissue preservation by anti-activated {beta}1 integrin therapy. J Am Soc Nephrol 2005, 16:374-382.
18. Racusen LC: Alterations in tubular epithelial cell adhesion and mechanisms of acute renal failure. Lab Invest 1992, 67:158-165.
19. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tarmenbeu SR: Analysis of nitrate; nitrite; and (15N)nitrate in biological fluids. Anal Biochem 1982, 126:131-138.
20. Ferrero ME: In vivo vascular leakage assay. Methods in Molecular Medicine 2003, 98:193-200.
21. Kishimoto TK, Jutila MA, Berg EL, Butcher EC: Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors. Science 1989, 245:1238-1241.
22. Guzik TJ, Korbut R, Adamek-Guzik T: Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol 2003, 54:469-87.
23. Egdell RM, Siminiak T, Sheridan DJ: Modulation of neutrophil activity by nitric oxide during acute myocardial ischaemia and reperfusion. Basic Res Cardiol 1994, 89:499-509.
24. Wong D, Prameya R, Dorovini-Zis K, Vincent SR: Nitric oxide regulates interactions of PMN with human brain microvessel endothelial cells. Biochem Biophys Res Commun 2004, 323:142-48.
25. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC: Hyperthension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995, 377:239-42.
26. Scneider R, Raff U, Vornberger N, Schmidt M, Freund R, Reber M, Schramm L, Gambayran S, Wanner C, Schmidt HH, Galle J: L-Arginine counteracts nitric oxide deficiency and improves the recovery phase of ischemic acute renal failure in rats. Kidney Int 2004, 64:216-25.
27. Yamasowa H, Shimizu S, Inoue T, Takaaoka M, Maatsumura Y: Endothelial nitric oxide contributes to the renal protective effects of ischemic preconditioning. J Pharmacol Exp Ther 2005, 312:153-59.
28. Takahashi T, Hato F, Yamane T, Fukumasu H, Suzuki K, Ogita S, Nishizawa Y, Kitagawa S: Activation of human neutrophil by cytokine-activated endothelial cells. Circ Res 2001, 88:422-29.
29. Li H, Hergert SM, Schafer SC, Brausch I, Yao Y, Huang Q, Mang C, Lehr HA, Forstermann U: Midostaurin upregulates eNOS gene expression and preserves eNOS function in the microcirculation of the mouse. Nitric Oxide 2005, 12:231-36.
30. +) in human pulmonary arterial endothelial cells (HPAEC). Free Radic Biol Med 1998, 25:314-20.
31. Martynowicz H, Skoczynska A, Wojakowska A, Turczyn B: Serum vasoactive agents in rats poisoned with cadmium. Int J Occup Med Environ Health 2004, 17:479-85.
32. Green DJ, O'Driscoll JG, Maiorana A, Scrimgeour NB, Weerasooriya R, Taylor RR: Effects of chelation with EDTA and vitamin B therapy on nitric oxide-related endothelial vasodilator function. din Exp Pharmacol Physiol 1999, 26:853-56.
33. Duffy SJ, Biegelsen ES, Holbrook M, Russell JD, Gokce N, Keaney JFJr, Vita JA: Iron chelation improves endothelial function in patients with coronary artery disease. Circulation 2001, 103:2799-2804.
34. Hafezi-Moghadam A, Simoncini T, Yang Z, Limbourg FP, Plumier JC, Rebsamen MC, Hsieh CM, Chui DS, Thomas KL, Prorock AJ, Laubach VE, Moskowitz MA, French BA, Ley K, Liao JK: Acute cardiovascular protective effects of corticosteroids are mediated by nontranscriptional activation of endothelial nitric oxide synthase. Nature Med 2002, 8:473-79.
35. Chiari PC, Bienengraeber MW, Weihrauch D, Krolikowski JG, Kersten JR, Warltier DC, Pagel PS: Role of endothelial nitric oxide synthase as a trigger and mediator of isoflurane-induced delayed preconditioning in rabbit myocardium. Anesthesiology 2005, 103:74-83.
36. Tsai SK, Lin SM, Huang CH, Hung WC, Chih CL, Huang SS: Effect of desflurane-induced preconditioning following ischemia-reperfusion on nitric oxide release in rabbits. Life Sci 2004, 76:651-60.
37. Fisher AE, Maxwell SC, Naughton DP: Superoxide and hydrogen peroxide suppression by metal ions and their EDTA complexes. Biochem Biophys Res Commun 2004, 316:48-51.
38. Hininger I, Waters R, Osman M, Garrel C, Fernholz K, Roussel AM, Anderson RA: Acute prooxidant effects of vitamin C in EDTA chelation therapy and long-term antioxidant benefits of therapy. Free Radic Biol Med 2005, 38:1565-70.